ICD10 code of Retinoblastoma and ICD9 code

Retinoblastoma is primarily classified under the ICD-10 code C69.2 (Malignant neoplasm of retina) and the ICD-9 code 190.2 (Malignant neoplasm of retina). These diagnostic codes are essential for medical billing, clinical documentation, and tracking the global incidence of this rare childhood eye cancer.

What is the clinical significance of the Retinoblastoma ICD classification?

In clinical practice, Retinoblastoma is a rare, malignant tumor that develops in the retina, typically affecting children under the age of five. The use of specific ICD (International Classification of Diseases) codes ensures that healthcare providers, insurance companies, and public health registries can accurately track Retinoblastoma cases. While ICD-10 code C69.2 is the primary designation, clinicians may also use sub-codes to specify laterality (left, right, or bilateral eye involvement). Accurate coding for Retinoblastoma is vital for ensuring that patients receive appropriate insurance coverage for specialized oncology and ophthalmology treatments.

What causes Retinoblastoma and is it hereditary?

Retinoblastoma is caused by mutations in the RB1 tumor suppressor gene located on chromosome 13q14. Approximately 40% of Retinoblastoma cases are hereditary, meaning the child inherits a germline mutation from a parent or develops the mutation in the egg or sperm. The remaining 60% of cases are sporadic, occurring due to a somatic mutation that happens randomly during early development. Understanding the genetic basis is critical, as children with a germline mutation are at a higher risk of developing secondary cancers later in life.

How is Retinoblastoma diagnosed and staged?

Early detection of Retinoblastoma is often triggered by parents noticing a "white glow" in the pupil (leukocoria), especially in photographs. Diagnosis requires a comprehensive examination under anesthesia by an ocular oncologist. To determine the appropriate course of treatment, clinicians use the International Classification of Retinoblastoma (ICRB), which evaluates the severity of the tumor. Key diagnostic and staging factors include:

• Leukocoria: The most common presenting sign, often noticed in flash photography.


• Strabismus: An inward or outward turning of the eye that can indicate vision loss.


• Ophthalmoscopy: Direct visualization of the retina to identify tumor size, location, and calcification.


• Imaging: MRI or ultrasound to assess the extent of the tumor and rule out spread to the optic nerve or beyond the eye.


• Genetic Testing: Blood testing to identify the specific RB1 mutation, which helps guide long-term monitoring.

How does the DiseaseMaps community support families affected by Retinoblastoma?

Receiving a diagnosis of Retinoblastoma is an overwhelming experience for any family. At DiseaseMaps.org, we currently have 8 members who have navigated the complexities of this rare condition. Connecting with others who understand the nuances of treatment, follow-up screenings, and the emotional toll of childhood cancer can provide invaluable support. Sharing experiences helps reduce the isolation often felt by caregivers managing the long-term surveillance required for Retinoblastoma survivors.

Next steps

• Consult a pediatric ocular oncologist immediately if you notice leukocoria or unexplained vision changes in a child.


• Request genetic counseling to determine if the Retinoblastoma diagnosis is sporadic or hereditary, which impacts family screening needs.


• Join the DiseaseMaps community to connect with other families who have firsthand experience with pediatric eye oncology.


• Maintain a strict schedule of follow-up ophthalmological exams, as long-term monitoring is essential for early detection of recurrences.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): https://rarediseases.info.nih.gov/diseases/7568/retinoblastoma


• Orphanet (ORPHA:790): https://www.orpha.net/


• OMIM (Online Mendelian Inheritance in Man): https://www.omim.org/entry/180200


• American Academy of Ophthalmology: https://www.aao.org/eye-health/diseases/what-is-retinoblastoma